Promoter holding
64.27%
SB
Scania Biotech Private Limited - Due diligence report
A 360° intelligence report on Scania Biotech: trust score, financial health, credit view, compliance, directors, growth and distress signals…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Scania Biotech — 360° Intelligence Report
Generated from MCA filings & public records82/100
Trust Score
Low Risk
Scania Biotech is assessed as Low Risk with a Trust Score of 82/100. Scania Biotech is an active private limited indian non-government company incorporated in 2005, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.
Report generated on 17 Aug 2026 from the latest processed filings. Scania Biotech Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
82/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
93/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
65/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 50/100 Moderate
- Negative operating earnings - debt service depends on external support.
- Profitable - internal accruals available.
Charges position: 1 open (44.66 Lakh) · 0 satisfied (-).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Hdfc Bank Limited | 1 | 48.0 cr |
Compliance Score: 93/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 1 court forum(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 90/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| SANJAY GADODIA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| UTKARSH GADODIA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- 1 director exit(s) in the last 3 years.
- Average tenure above 5 years.
06
Ownership & Group Intelligence
As per FY 2020 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
4 allotment(s) · 1 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 40 · Distress 75
Growth signals & trust indicators
Operating for 21+ years.
Distress signals & risk flags
Revenue declined year-on-year.
1 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence84/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment65/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 1 open charge(s) of 44.66 Lakh already registered.
- Compliance record supports lending.
Investor view59/100
Mixed indicators
Growth quality and scalability through an investor lens.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 14 events30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
02 Mar 2024
Director ceased
SIDDHARTH GADODIA
11 Mar 2022
Charge created
Hdfc Bank Limited - 44.66 Lakh
08 Sep 2021
Director appointed
SANJAY GADODIA (Director)
31 Mar 2017
Share transfer (FY 2017)
47.00000000 shares to SIDDHARTH
05 Dec 2016
Director ceased
SANJAY GADODIA
15 Nov 2016
Director ceased
SARITA GADODIA
30 Apr 2016
Securities allotted
61271 Equity Shares Without Differential Rights - 1.64 cr raised
13 Mar 2014
Securities allotted
28649 Equity Shares Without Differential Rights - 97.41 Lakh raised
16 Jul 2013
Securities allotted
14000 Equity Shares Without Differential Rights - 14.00 Lakh raised
20 Mar 2012
Securities allotted
9200 Equity Shares Without Differential Rights - 46.00 Lakh raised
01 Aug 2005
Incorporated
Registered with Roc Cuttack
Director appointed
UTKARSH GADODIA (Director)
10
Key Observations
Auto-generated from the data aboveRevenue declined 38% over the last 4 financial year(s).
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
Promoters hold a dominant controlling stake as per the FY 2020 annual return.
Capital has been raised through 4 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Saicast Autotech Private Limited | U27109UP2018PTC110848 | Ghaziabad, Uttar Pradesh, India |
| Flow Systems Private Limited | U27100MH1988PTC048630 | Thane, Maharashtra, India |
| Shree Sai Megha Alloys Ltd | U27107ML1996PLC004784 | Ri Bhoi, Meghalaya, India |
| Steeloy Rolling Mills Private Limited | U27100GJ2013PTC073221 | Kalol, Gujarat, India |
| Jaldhara Pumps Limited | L29120GJ1992PLC017722 | Mehsana, Gujarat, India |
| Shangov Tubes And Pipes Private Limited | U27109TG2006PTC049487 | Secunderabad, 026, Telangana, India |
| Sreevatsa Exports Private Limited | U27310TZ1992PTC003832 | Tamil Nadu, Tamil Nadu, India |
| Concept Engineers Pvt Ltd | U74210PN1985PTC036406 | Pune, Maharashtra, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Scania Biotech before audits and certifications: compliance score 93/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Scania Biotech: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 40/100, margin trends, ownership structure and peer set for Scania Biotech - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 82/100, distress signals and MSME payment-delay disclosures - know whether Scania Biotech pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Scania Biotech - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Scania Biotech an active company?
Scania Biotech has MCA status “Active” with a compliance score of 93/100 (Low Risk).
Is Scania Biotech financially healthy?
Scania Biotech has a Financial Health Score of 65/100 (Moderate) based on its filed financial statements.
Should I do business with Scania Biotech?
Its overall Trust Score is 82/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Scania Biotech?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.
Does Scania Biotech have loans or charges against its assets?
1 open charge(s) are registered against its assets.
Is Scania Biotech up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 93/100 (Low Risk).
Is it risky to lend to Scania Biotech?
Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
